. Boosting of antibodies to the head and stem epitopes of HA following vaccination with inactivated H1N1. Serum antibody titers against the head and stem of HA were measured by the ability of serum to block the binding of monoclonal antibodies that bind to the head and stem of HA, respectively. The BD 50 is proportional to the serum antibody titer against the head and stem epitopes [1] . Panel A shows antibody titers in terms of BD 50 measurements against HA head (red) and stem (blue) epitopes measured prevaccination and 30 days postvaccination. Panel B shows the fold-increase in antibody titers against HA head (red) and stem (blue) epitopes calculated from the data in panel A. Panel C shows the relationship between the pre-and postvaccination antibody titers. In the absence of boosting, we expect the data to fall on the dashed line (slope=1). If the degree of boosting is independent of the initial titer, boosting would result in the data falling on a line parallel to (and above) the dashed line. The solid line, representing the best fit line, has slope less than one (least squares; slope = 0.31; 95% CI=[0.086,0.532]), indicating that there is less boosting when initial antibody titers are high. Data are from [2] . Schematic for the three-epitope model with steric interference. Eight antigen states are shown. Unbound antigen (XY S) has three antibody binding sites, two on the head (i.e., X and Y ) and one on the stem (S). Sites that are bound by corresponding antibody are represented with an O; for example, antigen with just the stem-specific antibody bound is represented as XY O. Panel B-E: Fold increase in antibody to the head (X+Y ) and stem (S) as a function of preexisting humoral immunity to stem S (naive initial condition for humoral immunity to head epitopes X and Y ) in the three-epitope versions of the basic model, ACM, FIM and EMM, respectively. Parameters are in the Table 1 . For ACM parameter d b is equal 3, for FIM parameter α = 0.01 and α = 0 for other models. Figure E. Predictions of the models when different individuals vary in the level of pre-existing antibody to both head (red circles) and stem (blue triangles) epitopes. Using a three-epitope framework we calculate how different amounts of pre-existing immunity to the head and stem of HA affect boosting of the antibody responses to these epitopes in Basic model, ACM, FIM, EMM and all combinations of ACM, FIM and EMM (of two or all three models). We consider ten individuals (ten initial conditions) with different amounts of antibody to the head and stem of HA prior to immunization. linear on log-log plot threshold Supplemental Figure 6 Table B. Models parameter ranges, outcomes and robustness.
Model parameter
Model parameters such as decay rate of antibody (d A ) have been relatively accurately estimated in vivo [3] and we do not expect much variation. The maximum effective proliferation rate of B cells (s) was set in the range 1 ≤ s ≤ 2 which corresponds to division times between 1 and 0.5 days. The mean value of a was obtained by rescaling the concentration of antibodies so as to have A ≈ B at equilibrium, and we would expect little variation between individuals. Biological ranges for the antigen for half-maximum proliferation (φ) and decay rate of antigen (d f ) were estimated to allow the duration of antigenic stimulation for B cells to encompass a range of 3 to 14 days. Our model is robust to the value of the rate constant for antibody binding provided k > 0.01 which is needed for rapid binding of antibodies to the antigen compared with the duration of the response. We note that we have rescaled the concentrations of antigen, B cells and antibodies as described in the main text and for their concentrations we use the scaled unit s defined as ratio of specific antibody and B cells to their value prior to vaccination. The concentration of antibodies and antigen is scaled so that B ≈ A at equilibrium. The unit of time is one day. [2] . We would like to note that this vaccination study followed both prime and boost vaccination with inactivated H5N1 avian influenza virus. We focus on the data obtained following the boost for the following reason. Individuals in the prime vaccination study were divided into two groups with first group vaccinated with Vietnam strain and second group vaccinated with Indonesia strain of H5N1. Head-specific antibodies were measured by binding to the head of HA from the Indonesia strain. It has been shown previously [4] that little cross-reacting antibody against Indonesia antigen was induced by 2 doses of Vietnam vaccine and thus we did not use the data for evaluating the fold increase in the head antibody after prime vaccination. In contrast, all individuals received a boost with the same Indonesia strain and headspecific antibodies were measured by binding to the head of HA from the same Indonesia strain. Panel A. Basic model. 
Time (days)
Concentrations 0 10 30 50 1e+00 1e+09 1e+18 1e+27 k= 0.0082 df=db= 0.59 dA=a= 0.104 s= 1.62 phi= 48 free antigen antibody Time (days) Concentrations 0 10 30 50 1e+00 1e+09 1e+18 1e+27 k= 0.05 df=db= 0.91 dA=a= 0.0958 s= 1.29 phi= 19 free antigen antibody Time (days) Concentrations 0 10 30 50 1e+00 1e+09 1e+18 1e+27 k= 0.02 df=db= 0.28 dA=a= 0.0992 s= 1.21 phi= 32 free antigen antibody Time (days) Concentrations 0 10 30 50 1e+00 1e+09 1e+18 1e+27 k= 0.01 df=db= 0.66 dA=a= 0.106 s= 1.88 phi=
